NCT06925373 Housing, Environment, And Living Conditions for Transformed Health
| NCT ID | NCT06925373 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Lung Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 460 participants |
| Start Date | 2025-06-18 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 460 participants in total. It began in 2025-06-18 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will compare the health effects of public housing renovation, neighborhood built and social environment improvements, and indoor air purification, alone and in combination, as well as the cost effectiveness of each approach. STUDY 1: The study will assess the effects of public housing and neighborhood environment (built and social) improvements on health-related behaviors, psychosocial and physiologic stress, and self-reported and physiological markers of lung health and chronic disease. STUDY 2: The study will determine whether indoor air purification can positively impact lung health in public housing sites not undergoing housing renovation, comparing a site near industrial pollution vs one less contaminated.
Eligibility Criteria
Inclusion Criteria: * Adults age 18 years and older * English speaking * Residents of one of 4 public housing site in Birmingham, Alabama Exclusion Criteria: * Individuals who are not 18 years or older * Do not speak English * Do not meet the residency criteria
Contact & Investigator
Gabriela R Oates, PhD
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham (UAB)
Frequently Asked Questions
Who can join the NCT06925373 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Lung Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06925373 currently recruiting?
Yes, NCT06925373 is actively recruiting participants. Contact the research team at goates@uab.edu for enrollment information.
Where is the NCT06925373 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06925373 clinical trial?
NCT06925373 is sponsored by University of Alabama at Birmingham. The principal investigator is Gabriela R Oates, PhD at University of Alabama at Birmingham (UAB). The trial plans to enroll 460 participants.